Cybin (FRA:R7E1) EV-to-EBIT : -4.69 (As of May. 26, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Cybin EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cybin's Enterprise Value is €217.01 Mil. Cybin's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-46.29 Mil. Therefore, Cybin's EV-to-EBIT for today is -4.69.

The historical rank and industry rank for Cybin's EV-to-EBIT or its related term are showing as below:

FRA:R7E1' s EV-to-EBIT Range Over the Past 10 Years
Min: -16.78 Med: -1.53 Max: 0.52
Current: -4.78

During the past 4 years, the highest EV-to-EBIT of Cybin was 0.52. The lowest was -16.78. And the median was -1.53.

FRA:R7E1's EV-to-EBIT is ranked worse than
100% of 426 companies
in the Biotechnology industry
Industry Median: 10.295 vs FRA:R7E1: -4.78

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cybin's Enterprise Value for the quarter that ended in Dec. 2023 was €115.04 Mil. Cybin's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-46.29 Mil. Cybin's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -40.24%.

Cybin EV-to-EBIT Historical Data

The historical data trend for Cybin's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin EV-to-EBIT Chart

Cybin Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

EV-to-EBIT

-4.61

-1.81

-1.69

Cybin Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial										-1.04	-1.69	-1.87	-3.16	-2.63

Competitive Comparison of Cybin's EV-to-EBIT

For the Biotechnology subindustry, Cybin's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cybin's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cybin's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cybin's EV-to-EBIT falls into.

Cybin EV-to-EBIT Calculation

Cybin's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	217.010	/	-46.285
	=	-4.69

Cybin's current Enterprise Value is €217.01 Mil.
Cybin's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-46.29 Mil.

Cybin (FRA:R7E1) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cybin's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-46.285	/	115.035468
	=	-40.24 %

Cybin's Enterprise Value for the quarter that ended in Dec. 2023 was €115.04 Mil.
Cybin's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-46.29 Mil.

Cybin EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cybin's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Cybin (FRA:R7E1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (FRA:R7E1) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

CYBN:USA R7E1:Germany CYBN:Canada

Address

100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9

Website

https://www.cybin.com

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.

Cybin (FRA:R7E1) Headlines

No Headlines